jpnn.com, JAKARTA - BioNTech has announced that it has started developing a customized Covid-19 vaccine against the Omicron variant.
As is known, the Omicron variant was found in South Africa.
ALSO SEE: Countries Where Covid-19 Omicron Variant Has Existed
The company, which partnered with Pfizer, said development of a specific vaccine was part of the company's standard procedures for new variants.
However, BioNTech has not yet determined whether to remake an existing Covid-19 vaccine.
ALSO SEE: 5 Facts You Need to Know About Covid-19 Omicron Variant
"The first steps of developing a potential new vaccine overlap with the research necessary in order to evaluate whether a new shot will be needed," said BioNTech.
WHO said Omicron carried a very high risk of a global spike as more and more countries reported findings of the variant and pushed for border closures.
ALSO SEE: Travelers from These Countries Banned from Entering US
BioNTech said they expect more data from the lab in the next two weeks.
This will help determine whether it is necessary to produce an Omicron-specific vaccine.
Its competitor, Moderna, said it was redesigning their Covid-19 vaccine for use as a future booster vaccine. (antara/mcr20/jpnn)
This news has been broadcast on JPNN.com with the title: Angin Segar untuk Penanganan Varian Omicron, Semoga Berhasil